In subjects with ARDS, when MSCs were administered, 5 days post infusion, serum levels of surfactant protein D, an ALI biomarker, were significantly lowered as compared to baseline levels pre-infusion. The gene discussed is SFTPD; the disease is acute respiratory distress syndrome.